Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. FE [Internet]. 2014 Sep. 30 [cited 2025 Oct. 29];15(3). Available from: https://journals.seedstm.com/index.php/FE/article/view/938